2-piperidone has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashritha, N; El-Rayes, BF; Kandimalla, R; Ko, JE; Nagaraju, GP; Shoji, M; Snyder, JP; Zhu, S | 1 |
| Alam, A; Alese, OB; El-Rayes, BF; Nagaraju, GP; Pattnaik, S; Rajitha, B; Shaib, WL; Shoji, M; Snyder, JP | 1 |
| Anant, S; Awasthi, V; Dhar, A; Jensen, RA; Nicholes, ND; Subramaniam, D; Umar, S; Welch, DR | 1 |
| Larsen, L; Rosengren, RJ; Taurin, S; Yadav, B | 1 |
| Anant, S; Dieckgraefe, BK; George, R; Hideg, K; Houchen, CW; Kuppusamy, P; Lee, KB; May, R; Ramanujam, RP; Subramaniam, D; Sureban, SM | 1 |
| Alizadeh, AR; Kisiel, W; Liotta, DC; Lu, YJ; McCarey, BE; Mosley, CA; Nichols, C; Parker, ET; Pohl, J; Shim, H; Shoji, M; Snyder, JP; Sun, A | 1 |
6 other study(ies) available for 2-piperidone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Topics: Angiogenesis Inhibitors; Angiopoietins; Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Culture Media, Conditioned; Curcumin; Female; Gene Expression; HSP90 Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Pancreatic Neoplasms; Piperidones; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
Topics: Angiogenesis Inhibitors; Animals; Chickens; Colon; Colorectal Neoplasms; Curcumin; Female; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Piperidones; Pyridines; Rats; Rectum; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |
3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis.
Topics: Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Piperidones; Receptors, Notch; Xenograft Model Antitumor Assays | 2011 |
RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Piperidones; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzylidene Compounds; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; HCT116 Cells; HT29 Cells; Humans; Interleukin-8; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Neovascularization, Pathologic; Piperidones; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa.
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Endocytosis; Factor VIIa; Humans; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Piperidones; Rabbits; Thromboplastin; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |